Sign in

CIK 0001745999 · Large accelerated filer

Beam Therapeutics Inc.

Sign in to watch
Ticker
BEAM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857-327-8775
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Former names
Beam Therapeutics Inc.
  1. 4 Planned sale President sold 51,110 shares at $26.27 ($1,342,752)
  2. 4 Planned sale Chief Legal Officer sold 385 shares at $23.48 ($9,040)
  3. 4 Planned sale SVP, Finance and Treasurer sold 289 shares at $23.48 ($6,785)
  4. 4 Planned sale CEO sold 60,000 shares at $24.60 ($1,476,024)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Planned sale Chief Medical Officer sold 1,250 shares at an average $23.28 ($29,094)
  8. 4 Planned sale CEO sold 60,000 shares at $24.50 ($1,470,156)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award Chief Financial Officer acquired 12,500 shares (grant or award)
  16. 4 Planned sale Chief Medical Officer sold 23,687 shares at an average $31.02 ($734,805)
  17. 4 Planned sale Chief Legal Officer sold 3,401 shares at $32.12 ($109,240)
  18. 4 Planned sale Chief Financial Officer sold 5,446 shares at $32.12 ($174,926)
  19. 4 Planned sale CEO sold 18,102 shares at $32.13 ($581,617)
  20. 4 Planned sale President sold 4,534 shares at $32.12 ($145,632)

Page 5 of 12 · 238 filings